510(k) Report

510(k) · Cleared

Cleared

Cardio10

K220535510(k) TraditionalCleared Nov 15, 2022264-day reviewClass II21 CFR 870.2340

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bionet Co., Ltd. · DPS Electrocardiograph

Cleared on Nov 15, 2022 as substantially equivalent to K113306 (Bionet Co., Ltd., 2012) and 1 other predicate after a 264-day review. Its family tree reaches back 6 generations to 1990. 2 later devices descend from it.

Decided
Nov 15, 2022
Review
264 days
Class
Class II
Product code
DPS
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K895520 (1990). 14 ancestors in all. 2 later devices descend from it, 2 citing it directly.

  1. Root · 6 generations backK895520 Pagewriter Xli M1700A & Pagewriter XL M1701AHewlett-Packard Co. · 1990
  2. 5 generations backK020708 Philips Pagewriter Touch Cardiograph, Model M5000A SeriesPhilips Medical Systems, Inc. · 2002 · Recalled
  3. 4 generations backK031422 Philips Page Writer Trim Series Cardiograph Including I, II, Iii…Philips Medical Systems · 2003
  4. 3 generations backK072449 CP100 & 200 12-Lead Resting ElectrocardiographsWelch Allyn, Inc. · 2007
  5. 2 generations backK102767 Cardio XPBionet Co., Ltd. · 2011
  6. 1 generation backK113306 Cardio 7Bionet Co., Ltd. · 2012
  7. This deviceK220535 Cardio10Bionet Co., Ltd. · 2022
  8. Descendant · cites it directly · 0 of its ownK231160 Cardio Q50, Cardio Q70Bionet Co., Ltd. · 2023
  9. Descendant · cites it directly · 0 of its ownK231150 Cardio P1Bionet Co., Ltd. · 2023

Most influential descendants

Showing 2 of 2 · See all
  • K231160Cardio Q50, Cardio Q70Bionet Co., Ltd. · 2023 · cites it directly0descendants
  • K231150Cardio P1Bionet Co., Ltd. · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K895520Pagewriter Xli M1700A & Pagewriter XL M1701AHewlett-Packard Co.1990—
−5K020708Philips Pagewriter Touch Cardiograph, Model M5000A SeriesPhilips Medical Systems, Inc.20022
−4K031422Philips Page Writer Trim Series Cardiograph Including I, II, Iii, Models…Philips Medical Systems2003—
−3K072449CP100 & 200 12-Lead Resting ElectrocardiographsWelch Allyn, Inc.2007—
−2K102767Cardio XPBionet Co., Ltd.2011—
−1K113306Cardio 7Bionet Co., Ltd.2012—
0 (this device)K220535Cardio10Bionet Co., Ltd.2022—
+1K231160Cardio Q50, Cardio Q70Bionet Co., Ltd.2023—
+1K231150Cardio P1Bionet Co., Ltd.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199810
200030
200910
201320

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202320
FIG. 1 — Lineage of K220535, 1990–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DPS device

  1. #1 K212112 Cardiologs Holter Platformscore 18.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113306Cardio 7
Summary page 5
…te Device(s) [21 CFR 807.92(a)(3)] The identified predicate devices within this submission are shown as follow; Predicate device ⚫ 510(k) Number: K113306 ⚫ Applicant: Bionet Co., Ltd. ⚫ Trade/Device Name Cardio7 ⚫ Regulation Number 870.2…
Bionet Co., Ltd.2012—
*K130322SPM-300
Summary page 5
…gulation Name: Electrocardiograph ⚫ Regulation Class: 2 ⚫ Product Code: DPS Reference device ⚫ 510(k) Number: K130322 ⚫ Applicant: Bionet Co., Ltd. ⚫ Trade/Device Name SPM-300 ⚫ Regulation Number 868.1…
Bionet Co., Ltd.2013—

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K231160Cardio Q50, Cardio Q70Bionet Co., Ltd.20230
K231150Cardio P1Bionet Co., Ltd.20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 32 years and passes through 5 companies; a new generation was cleared every 4.4 years on median.
  • 1 of the 14 ancestors has a recall of any class.
  • Of its descendants, K231160 (Bionet Co., Ltd., 2023) has gone furthest, with 0 descendants of its own.

How does its category compare?

All DPS devices

DPS Electrocardiograph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · DPS

6in 2025

2007: 112008: 132009: 142010: 112011: 222012: 122013: 102014: 112015: 82016: 112017: 92018: 142019: 32020: 62021: 52022: 62023: 102024: 82025: 62026 (partial year): 6
2007high 22 (2011) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DPS

163in 2025

2007: 87 days median2008: 31 days median2009: 84 days median2010: 104 days median2011: 154 days median2012: 117 days median2013: 134 days median2014: 253 days median2015: 178 days median2016: 229 days median2017: 177 days median2018: 221 days median2019: 178 days median2020: 224 days median2021: 135 days median2022: 244 days median2023: 236 days median2024: 260 days median2025: 163 days median2026 (partial year): 258 days median
2007high 260 (2024) · low 31 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DPS

3in 2025

2007: 22009: 12010: 22011: 12019: 92020: 22021: 12022: 12023: 32024: 4, 1 Class I2025: 32026 (partial year): 4
2007high 9 (2019) · low 0 (2008)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · DPS

55in 2025

2007: 92008: 172009: 142010: 212011: 1212012: 562013: 152014: 152015: 302016: 122017: 152018: 192019: 272020: 592021: 242022: 592023: 542024: 642025: 55
2007high 121 (2011) · low 9 (2007)2025

MAUDE reports naming product code DPS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007118729
20081331017
20091484114
201011104221
2011221541121
201212117056
201310134015
201411253015
20158178030
201611229012
20179177015
201814221019
20193178927
20206224259
20215135124
20226244159
202310236354
202482604 (1)64
20256163355
202662584—

What is it indicated for?

The Cardio10 ECG Analysis System is intended to acquire, analyze, display, and record electrocardiographic information from adult and pediatric populations. Pediatric population is defined as patients between the ages from 3 and less than 16 years. Basic systems deliver 12 lead ECG’s, interpretive analysis, and can be upgraded to provide software analysis options such as a high resolution signal averaging of QRS and P wave portions of the…

Read the full statement (187 words)

The Cardio10 ECG Analysis System is intended to acquire, analyze, display, and record electrocardiographic information from adult and pediatric populations.

Pediatric population is defined as patients between the ages from 3 and less than 16 years.

Basic systems deliver 12 lead ECG’s, interpretive analysis, and can be upgraded to provide software analysis options such as a high resolution signal averaging of QRS and P wave portions of the electrocardiogram. The 12-lead ECG interpretive algorithm provides a computer-generated analysis of potential patient cardiac abnormalities, which must be confirmed by a physician with other relevant clinical information.

Transmission and reception of ECG data to and from a central ECG cardiovascular information system is optional.

The Cardio10 is intended to be used under the direct supervision of a licensed healthcare practitioner, by trained operators in a hospital or medical professional’s facility.

Cardio10 is intended for prescription use only to conduct diagnostic spirometry testing of adults and pediatric patients, 5 years and older, in general practice, specialty physician, and hospital settings. The device is intended to be used as a spirometer which measures patient respiratory parameters including FVC, COPD, SVC, MVV.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K220535: Cardio10.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K220535

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026